{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:06:17Z","timestamp":1765886777388},"reference-count":22,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We\nreport the discovery and characterization of a novel ribosome inhibitor\n(NRI) class that exhibits selective and broad-spectrum antibacterial\nactivity. Compounds in this class inhibit growth of many gram-positive\nand gram-negative bacteria, including the common respiratory pathogens\n            <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n            ,\n            <jats:italic>Haemophilus influenzae<\/jats:italic>\n            ,\n            <jats:italic>Staphylococcus aureus<\/jats:italic>\n            , and\n            <jats:italic>Moraxella catarrhalis<\/jats:italic>\n            , and\nare nontoxic to human cell lines. The first NRI was discovered in a\nhigh-throughput screen designed to identify inhibitors of cell-free\ntranslation in extracts from\n            <jats:italic>S. pneumoniae.<\/jats:italic>\n            The chemical\nstructure of the NRI class is related to antibacterial quinolones, but,\ninterestingly, the differences in structure are sufficient to\ncompletely alter the biochemical and intracellular mechanisms of\naction. Expression array studies and analysis of NRI-resistant mutants\nconfirm this difference in intracellular mechanism and provide evidence\nthat the NRIs inhibit bacterial protein synthesis by inhibiting\nribosomes. Furthermore, compounds in the NRI series appear to inhibit\nbacterial ribosomes by a new mechanism, because NRI-resistant strains\nare not cross-resistant to other ribosome inhibitors, such as\nmacrolides, chloramphenicol, tetracycline, aminoglycosides, or\noxazolidinones. The NRIs are a promising new antibacterial class with\nactivity against all major drug-resistant respiratory\npathogens.\n          <\/jats:p>","DOI":"10.1128\/aac.47.12.3831-3839.2003","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T22:53:35Z","timestamp":1069714415000},"page":"3831-3839","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["Novel AntibacterialClass"],"prefix":"10.1128","volume":"47","author":[{"given":"Peter J.","family":"Dandliker","sequence":"first","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve D.","family":"Pratt","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Nilius","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace","family":"Black-Schaefer","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoan","family":"Ruan","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danli L.","family":"Towne","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard F.","family":"Clark","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika E.","family":"Englund","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Wagner","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Weitzberg","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda E.","family":"Chovan","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Hickman","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa M.","family":"Daly","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Kakavas","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhong","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhensheng","family":"Cao","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline A.","family":"David","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Xuei","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude G.","family":"Lerner","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niru B.","family":"Soni","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Bui","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linus L.","family":"Shen","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingna","family":"Cai","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Merta","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Y. C.","family":"Saiki","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Beutel","sequence":"additional","affiliation":[{"name":"Global\rPharmaceutical Research and Development, Abbott Laboratories, Abbott\rPark, Illinois 60064"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907223410403"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.4065\/75.11.1161"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(95)00485-O"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1721-1729.2001"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf808"},{"key":"e_1_3_1_7_2","unstructured":"Gale E. F. E. Cundliffe P. E. Reynolds M.\nH. Richmond and M. J. Waring. 1981.\nMolecular basis of antibiotic action. John Wiley and Sons London United\nKingdom."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.157701"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.7.2147-2150.2001"},{"key":"e_1_3_1_10_2","first-page":"501","volume":"5","year":"2002","unstructured":"Knowles, D. J. C., N. Foloppe, N. B. Matassova, and A. I. Murchie. 2002. The bacterial ribosome, a promising focus for structure-based drug design.Curr. Opin. Pharmacol.5:501-506.","journal-title":"Curr. Opin. Pharmacol."},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(94)00481-7"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/35080045"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.120.3.1300-1307.1974"},{"key":"e_1_3_1_14_2","unstructured":"Mackie G. A. C. Donly and P. C. Wong. 1990\n. Coupled transcription\/translation of ribosomal\nproteins p. 191-211. In G.\nSpedding (ed.) Ribosomes and protein synthesis: a practical approach.\nOxford University Press New York N.Y."},{"key":"e_1_3_1_15_2","unstructured":"National\nCommittee for Clinical Laboratory Standards. 1997.\nMethods for dilution antimicrobial susceptibility tests for bacteria\nthat grow aerobically. Document no. M7-A4. National Committee for\nClinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.185.1.359-370.2003"},{"key":"e_1_3_1_17_2","first-page":"473","volume":"3","year":"1993","unstructured":"Pag\u00e9, B., M. Pag\u00e9, and C. No\u00ebl. 1993. A fluorometric assay for cytotoxicity measurements in vitro.Int. J. Oncol.3:473-476.","journal-title":"Int. J. Oncol."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.mi.25.100171.002415"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.7.1574"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)81708-8"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00217518"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez D. 1979. Inhibitors of protein sythesis.\nSpringer-Verlag New York N.Y.","DOI":"10.1007\/978-3-642-81309-2"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432603"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.12.3831-3839.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.12.3831-3839.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:43:07Z","timestamp":1645465387000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.12.3831-3839.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1128\/AAC.47.12.3831-3839.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.12.3831-3839.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"2003-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}